GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Oxford Nanopore Technologies PLC (OTCPK:ONTTF) » Definitions » Asset Turnover

ONTTF (Oxford Nanopore Technologies) Asset Turnover : 0.11 (As of Jun. 2024)


View and export this data going back to 2021. Start your Free Trial

What is Oxford Nanopore Technologies Asset Turnover?

Asset Turnover measures how quickly a company turns over its asset through sales. It is calculated as Revenue divided by Total Assets. Oxford Nanopore Technologies's Revenue for the six months ended in Jun. 2024 was $107.0 Mil. Oxford Nanopore Technologies's Total Assets for the quarter that ended in Jun. 2024 was $951.5 Mil. Therefore, Oxford Nanopore Technologies's Asset Turnover for the quarter that ended in Jun. 2024 was 0.11.

Asset Turnover is linked to ROE % through Du Pont Formula. Oxford Nanopore Technologies's annualized ROE % for the quarter that ended in Jun. 2024 was -24.49%. It is also linked to ROA % through Du Pont Formula. Oxford Nanopore Technologies's annualized ROA % for the quarter that ended in Jun. 2024 was -19.96%.


Oxford Nanopore Technologies Asset Turnover Historical Data

The historical data trend for Oxford Nanopore Technologies's Asset Turnover can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Oxford Nanopore Technologies Asset Turnover Chart

Oxford Nanopore Technologies Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Asset Turnover
Get a 7-Day Free Trial 0.31 0.52 0.24 0.23 0.22

Oxford Nanopore Technologies Semi-Annual Data
Dec18 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
Asset Turnover Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only 0.14 0.09 0.11 0.11 0.11

Competitive Comparison of Oxford Nanopore Technologies's Asset Turnover

For the Biotechnology subindustry, Oxford Nanopore Technologies's Asset Turnover, along with its competitors' market caps and Asset Turnover data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Oxford Nanopore Technologies's Asset Turnover Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Oxford Nanopore Technologies's Asset Turnover distribution charts can be found below:

* The bar in red indicates where Oxford Nanopore Technologies's Asset Turnover falls into.



Oxford Nanopore Technologies Asset Turnover Calculation

Asset Turnover measures how quickly a company turns over its asset through sales.

Oxford Nanopore Technologies's Asset Turnover for the fiscal year that ended in Dec. 2023 is calculated as

Asset Turnover
=Revenue/Average Total Assets
=Revenue (A: Dec. 2023 )/( (Total Assets (A: Dec. 2022 )+Total Assets (A: Dec. 2023 ))/ count )
=214.77/( (1003.52+983.623)/ 2 )
=214.77/993.5715
=0.22

Oxford Nanopore Technologies's Asset Turnover for the quarter that ended in Jun. 2024 is calculated as

Asset Turnover
=Revenue/Average Total Assets
=Revenue (Q: Jun. 2024 )/( (Total Assets (Q: Dec. 2023 )+Total Assets (Q: Jun. 2024 ))/ count )
=106.975/( (983.623+919.406)/ 2 )
=106.975/951.5145
=0.11

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Companies with low profit margins tend to have high Asset Turnover, while those with high profit margins have low Asset Turnover. Companies in the retail industry tend to have a very high turnover ratio.


Oxford Nanopore Technologies  (OTCPK:ONTTF) Asset Turnover Explanation

Asset Turnover is linked to ROE % through Du Pont Formula.

Oxford Nanopore Technologies's annulized ROE % for the quarter that ended in Jun. 2024 is

ROE %**(Q: Jun. 2024 )
=Net Income/Total Stockholders Equity
=-189.954/775.554
=(Net Income / Revenue)*(Revenue / Total Assets)*(Total Assets / Total Stockholders Equity)
=(-189.954 / 213.95)*(213.95 / 951.5145)*(951.5145/ 775.554)
=Net Margin %*Asset Turnover*Equity Multiplier
=-88.78 %*0.2249*1.2269
=ROA %*Equity Multiplier
=-19.96 %*1.2269
=-24.49 %

Note: The Net Income data used here is two times the semi-annual (Jun. 2024) net income data. The Revenue data used here is two times the semi-annual (Jun. 2024) revenue data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

** The ROE % used above is for Du Pont Analysis only. It is different from the defined ROE % page on our website, as here it uses Net Income instead of Net Income attributable to Common Stockholders in the calculation.

It is also linked to ROA % through Du Pont Formula:

Oxford Nanopore Technologies's annulized ROA % for the quarter that ended in Jun. 2024 is

ROA %(Q: Jun. 2024 )
=Net Income/Total Assets
=-189.954/951.5145
=(Net Income / Revenue)*(Revenue / Total Assets)
=(-189.954 / 213.95)*(213.95 / 951.5145)
=Net Margin %*Asset Turnover
=-88.78 %*0.2249
=-19.96 %

Note: The Net Income data used here is two times the semi-annual (Jun. 2024) net income data. The Revenue data used here is two times the semi-annual (Jun. 2024) revenue data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Therefore, it is a good sign if a company's Asset Turnover is consistent or even increases. If a company's asset grows faster than sales, its Asset Turnover will decline, which can be a warning sign.


Oxford Nanopore Technologies Asset Turnover Related Terms

Thank you for viewing the detailed overview of Oxford Nanopore Technologies's Asset Turnover provided by GuruFocus.com. Please click on the following links to see related term pages.


Oxford Nanopore Technologies Business Description

Traded in Other Exchanges
Address
Edmund Halley Road, Gosling Building, Oxford Science Park, Oxford, Oxfordshire, GBR, OX4 4DQ
Oxford Nanopore Technologies PLC makes a novel generation of DNA/RNA sequencing technology that provides rich data and is fast, accessible, and easy to use. The company is predominantly involved in researching, developing, manufacturing, and commercializing a nanopore-based sequencing platform that allows the real-time analysis of deoxyribonucleic acid (DNA) or ribonucleic acid (RNA). This enables its customers to perform scientific/biomedical research in a range of areas, including human genetics, cancer research, outbreak surveillance, environmental analysis, pathogens/antimicrobial resistance, microbiome analysis, and crop science. The company's reportable segments are; Life Science Research Tools which generates key revenue, and COVID Testing.